© 2021 MJH Life Sciences and Pharmacy Times. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmacy Times. All rights reserved.
June 10, 2021
The results of the study are consistent with several large-scale epidemiological studies that show an association between Parkinson and inflammatory bowel diseases, such as ulcerative colitis and Crohn disease.
May 06, 2021
According to the authors of the study, the findings could lead to new therapies for inflammatory bowel disease and people who've had portions of their bowels removed due to conditions such as colon cancer and ulcerative colitis.
April 30, 2021
If gut-imprinted immune cells are diluted in comparison to immune cells triggered by other parts of the body, there could be implications for the oral-based COVID-19 vaccines currently under development.
April 16, 2021
Nivolumab is the first and only immunotherapy in combination with chemotherapy to deliver superior overall survival compared to chemotherapy alone in this patient population.
April 12, 2021
The data were presented for the first time at the virtual 2021 American Association for Cancer Research (AACR) Annual Meeting, April 10-15, 2021.
April 05, 2021
Risk factors for norovirus include eating foods in non-sanitary places and attending childcare centers or preschools.
February 25, 2021
The approval makes adalimumab the only subcutaneous biologic for pediatric patients with ulcerative colitis that can be administered at home.
February 16, 2021
Data from the FIGHT trial suggests that approximately 30% of patients with non-human epidermal growth factor 2-positive GEJ cancers overexpress fibroblast growth factor receptor 2.
February 11, 2021
The efficacy results demonstrated that there were 4 patients with confirmed partial response, and an additional 3 patients had stable disease lasting 16 weeks or longer.
January 11, 2021
A significantly greater proportion of patients with Crohn disease achieved both primary endpoints with overall safety results generally consistent with the known safety profile of risankizumab.